$68.28
Above FV▼ -36.2% against the close used
Model range $28.11 – $98.15
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear$28.11Fair value$68.28Bull$98.15
FairClose
52-week traded range
52W low $105.6952W high $152.95
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Xylem Inc. closed at $106.96, 56.6% above the consensus fair value of $68.28 drawn from 9 valuation models.
Financial DNA score 51/100 — Good. P/E of 27.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
$66.61
-37.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=7.2%, r=10%, tg=3%, n=10yr
Graham Number
$62.31
-41.7%
√(22.5 × EPS × BVPS)
EPS=3.92, BVPS=44.02 · outside Graham range (P/E 27.3, P/B 2.4) — asset-light, treat as a rough floor
P/E Fair Value
$78.40
-26.7%
EPS × 20x (sector P/E)
EPS=3.92, Sector P/E=20x
Peter Lynch (PEG)
$28.11
-73.7%
EPS × Growth% (PEG = 1 is fair)
EPS=3.92, g=7.2%
EV/EBITDA
$98.15
-8.2%
(EBITDA × 13.6x − Net Debt) ÷ Shares
EBITDA=1.8B
Dividend Discount (DDM)
$60.76
-43.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=1.6, r=10%, g=7.2%
Book Value (P/B)
$34.99
-67.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=44.02, ROE=9.2%, g=6%, r=10%
Reverse DCF
$106.96
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.3% | Historical: 7.2%
Margin of Safety
$51.83
-51.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=69.11, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.